UF-Membrane Refining and Impurity Removal System: Pharmaceutical-Grade Purification for Critical Flu

Name: UF-Membrane Refining and Impurity Removal System: Pharmaceutical-Grade Purification for Critical Flu
Rating: 5.0 (1 reviews)

Pharmaceutical-Grade Purity

Material Integrity

Energy Efficiency:

Zero Contamination Risk

Scalability

Cost Savings

Advanced Ultrafiltration Technology for Uncompromised Purity

Chlory UF-Membrane Refining and Impurity Removal System leveragesprecision ultrafiltration (UF) membrane technologyto achieve molecular-level separation of macromolecules, colloids, and microorganisms. Designed for pharmaceutical, biotechnology, and high-purity chemical applications, this system operates at ≤0.7 MPa pressure and ambient temperatures (5–45°C/75°C), eliminating thermal degradation risks while ensuring >99% removal of impurities. As a national high-tech enterprise with 40+ patents and 2,000+ industrial deployments, Xihe Flow guarantees compliance with pharmacopeia standards for critical processes like injectable purification and biologics desalination.

Process Flow: Molecular Sieving for Absolute Clarity

The UF system employs apressure-driven cross-flow filtration processthat separates impurities without chemical additives:

Feed Pressurization: Raw material enters under controlled pressure (≤0.7 MPa).
Selective Separation: UF membranes retain macromolecules (>1,000–500,000 Da), colloids, and microorganisms while allowing solvents and small molecules to permeate.
Output Streams:
- Retentate: Concentrated impurities (e.g., endotoxins, proteins) for disposal.
- Permeate: Purified fluid ready for final formulation.
  
  Closed-loop, automated, and ISO-compliant operation.

The membrane separation process relies on precise molecular-level screening. Feed liquid containing water, small molecules, and large particles passes through semi-permeable membranes. Water and small molecules permeate, while large particles are retained as concentrate.

Key Advantages

Pharmaceutical-Grade Purity: Removes >99% endotoxins, viruses, and colloids for injectables (e.g., WFI, monoclonal antibodies).
Material Integrity: Gentle room-temperature processing preserves APIs, enzymes, and heat-sensitive compounds.
Energy Efficiency: 70% lower energy consumption vs. centrifugation/diatomaceous earth filtration.
Zero Contamination Risk: No chemical additives; fully autoclavable (SIP/CIP compatible).
Scalability: Modular design supports capacities from 50 to 8,000 kg/h.
Cost Savings: Membranes reusable for 2–3 years with cleanable surfaces.

Technical Specifications

Model	Capacity (kg/h)	Power (kW)	Pressure (MPa)	Temperature (°C)
XH-UF4040-1X	50–100	2.2	≤0.7	5–45/75
XH-UF4040-2X	100–150	2.2	≤0.7	5–45/75
XH-UF4040-4X	150–250	4.0	≤0.7	5–45/75
XH-UF4040-6X	250–300	5.5	≤0.7	5–45/75
XH-UF8040-1X	150–300	4.0	≤0.7	5–45/75
XH-UF8040-2X	300–600	4.0	≤0.7	5–45/75
XH-UF8040-4X	600–1,000	7.5	≤0.7	5–45/75
XH-UF8040-6X	1,000–1,500	7.5	≤0.7	5–45/75
XH-UF8040-8X	1,500–2,000	7.5	≤0.7	5–45/75
XH-UF8040-9X	1,800–2,500	11	≤0.7	5–45/75
XH-UF8040-12X	2,500–3,500	11	≤0.7	5–45/75
XH-UF8040-15X	3,500–4,500	15	≤0.7	5–45/75
XH-UF8040-16X	4,000–5,000	22	≤0.7	5–45/75
XH-UF8040-18X	4,500–5,500	22	≤0.7	5–45/75
XH-UF8040-20X	5,000–6,000	22	≤0.7	5–45/75
XH-UF8040-24X	6,000–8,000	30	≤0.7	5–45/75

Custom configurations available for specialized needs.

Industry Applications

Pharmaceuticals:
- Purification of injections (e.g., double Coptis injection), oral liquids, and biologics.
- Removal of pyrogens and aggregates in monoclonal antibodies.
Biotech:
- Fermentation broth clarification and enzyme purification.
Food & Beverage:
- Juice/wine clarification and stability enhancement.
Chemicals:
- Polymer fractionation and catalyst recovery.